![Mark G. Cipriano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark G. Cipriano
Chief Executive Officer at
GLWL Research, Inc.
Profile
Mark G.
Cipriano currently works at GLWL Research, Inc., as Chief Executive & Financial Officer and Esperas Pharma Inc., as Chief Financial Officer.
Mr. Cipriano also formerly worked at Rapid Micro Biosystems, Inc., as Director, Transave, Inc., as Director, Ascent Venture Management Inc., as Director of Finance from 1998 to 1999, PricewaterhouseCoopers LLP, as Auditor, and TVM Capital Corp., as General Partner.
Mr. Cipriano received his undergraduate degree from Suffolk University.
Mark G. Cipriano active positions
| Companies | Position | Start |
|---|---|---|
Esperas Pharma Inc.
 Esperas Pharma Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Director of Finance/CFO | - |
GLWL Research, Inc.
 GLWL Research, Inc. Medical/Nursing ServicesHealth Services Develops and proofs compounds for treatment of diabetes | Chief Executive Officer | - |
Former positions of Mark G. Cipriano
| Companies | Position | End |
|---|---|---|
Transave, Inc.
 Transave, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics to treat chronic respiratory infections | Director/Board Member | 30/08/2012 |
Ascent Venture Management Inc.
 Ascent Venture Management Inc. Investment ManagersFinance Ascent Venture Partners invests in companies located in the United States. The firm targets companies operating in the field of the enterprise IT sector. It provides financing for early stage capital requirements with an investment size of USD 2 - 8 million. It acts as a lead investor and takes a seat on the board of directors. | Director of Finance/CFO | 31/12/1999 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Comptroller/Controller/Auditor | 31/12/1997 |
| RAPID MICRO BIOSYSTEMS, INC. | Director/Board Member | - |
TVM Capital Corp.
 TVM Capital Corp. Investment ManagersFinance TVM Capital invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in earlystage capital requirements. | Chief Investment Officer | 03/01/2011 |
Training of Mark G. Cipriano
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Rapid Micro Biosystems, Inc.
 Rapid Micro Biosystems, Inc. Industrial MachineryProducer Manufacturing Develops automation solutions for pharmaceutical and healthcare manufacturing products | Producer Manufacturing |
Suffolk University
 Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transave, Inc.
Transave, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics to treat chronic respiratory infections | Health Technology |
TVM Capital Corp.
TVM Capital Corp. Investment ManagersFinance TVM Capital invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in earlystage capital requirements. | Finance |
Ascent Venture Management Inc.
Ascent Venture Management Inc. Investment ManagersFinance Ascent Venture Partners invests in companies located in the United States. The firm targets companies operating in the field of the enterprise IT sector. It provides financing for early stage capital requirements with an investment size of USD 2 - 8 million. It acts as a lead investor and takes a seat on the board of directors. | Finance |
GLWL Research, Inc.
GLWL Research, Inc. Medical/Nursing ServicesHealth Services Develops and proofs compounds for treatment of diabetes | Health Services |
Esperas Pharma Inc.
Esperas Pharma Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Mark G. Cipriano
